Besides contrasting these findings using publicly available data, in this study we hypothesized that ROS1+ NSCLC is defined by specific transcriptomic signatures compared to other oncogene-driven tumors like ALK+ or RET+ lung adenocarcinomas. The gene discussed is ALK; the disease is non-small cell lung carcinoma.